Articles
Interventions for fertility preservation in women with cancer undergoing chemotherapy
For cancer patients undergoing chemotherapy, a review found that GnRH agonists may significantly reduce ovarian insufficiency in breast cancer, though other evidence is very uncertain. There's no clear evidence on live births or overall survival for either ovarian suppression or ovarian hyperstimulation with oocyte/embryo freezing, nor direct comparisons between the two.
Anti‐cancer drugs can be toxic to healthy cells in the body and have the potential to cause irreversible damage to ovarian tissue. This may lead to premature ovarian insufficiency. There are two main strategies to preserve fertility in women undergoing chemotherapy treatment for cancer.
Click here to access the article.